4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-22-010393
Director acquired 1,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCHEINBERG DAVID A Director | 2022-01-31 | Grant or award | +1,900 | 2,082 | D | ||
| Derivatives | |||||||
| SCHEINBERG DAVID A Director | 2022-01-31 | Grant or award · Stock Option (Right to Buy) | +7,125 | 7,125 | D | ||
Loading xslF345X03/tm225088-2_4seq1.xml…